Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Debt / NOTE 0.599% 8/0
-
Unit price / market price
-
$1.07
-
Total 13F principal
-
$445,463,135
-
Principal change
-
+$14,155,445
-
Total reported value
-
$478,977,819
-
Number of holders
-
51
-
Value change
-
+$16,292,881
-
Number of buys
-
28
-
Number of sells
-
14
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 as of Q4 2020
As of 31 Dec 2020 BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 had 51 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $445,463,135 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included ADVENT CAPITAL MANAGEMENT /DE/, MACKAY SHIELDS LLC, PFM Health Sciences, LP, LAZARD ASSET MANAGEMENT LLC, Allianz Asset Management GmbH, MORGAN STANLEY, SHENKMAN CAPITAL MANAGEMENT INC, STATE STREET CORP, BAKER BROS. ADVISORS LP, and Man Group plc.
This table shows 51 bond principal holders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.